NextPlat (NXPL) Research & Development (2011 - 2013)
NextPlat's (NXPL) quarterly Research & Development came in at $5000.0 in Q1 2013, down 54.33% year-over-year from $10949.0 in Q1 2012, and down 94.03% quarter-over-quarter from $83701.0 in Q3 2012.
Analysis
NextPlat (NXPL) Research & Development (2011 - 2013) Analysis & Trends
NextPlat (NXPL) has reported Research & Development for 3 consecutive years, with $5000.0 the latest figure, recorded in Q1 2013.
- On a quarterly basis, Research & Development fell 54.33% year-over-year to $5000.0 in Q1 2013; TTM through Mar 2013 was $296549.0, a 77.24% increase from a year earlier, with the FY2012 full-year figure at $115832.0, down 25.92% from the prior year.
- Research & Development was $5000.0 for Q1 2013 at NextPlat, down from $83701.0 in the prior quarter.
- Over five years, Research & Development peaked at $196899.0 in Q2 2012 and troughed at $5000.0 in Q1 2013.
- A 3-year average of $64701.7 and a median of $61620.0 in 2011 frame the typical range for Research & Development.
- Across the five-year window, Research & Development soared 219.54% in 2012 and slumped 54.33% in 2013, its largest moves.
- Over 3 years, Research & Development stood at $31451.0 in 2011, then surged by 166.13% to $83701.0 in 2012, then tumbled by 94.03% to $5000.0 in 2013.
- The last three Research & Development figures came in at $5000.0 (Q1 2013), $83701.0 (Q3 2012), and $196899.0 (Q2 2012), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 970.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 248.30 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 60.90 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 39.02 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 173.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 14.75 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -21.86 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 22.16 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 10.66 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2013 | 5,000.00 |
| Sep 30, 2012 | 83,701.00 |
| Jun 30, 2012 | 196,899.00 |
| Mar 31, 2012 | 10,949.00 |
| Dec 31, 2011 | 31,451.00 |
| Sep 30, 2011 | 63,292.00 |
| Jun 30, 2011 | 61,620.00 |